Related Experiment Video

Updated: Sep 1, 2025

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons
07:43

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons

Published on: January 7, 2019

7.0K

Amyotrophic lateral sclerosis from genotoxins alone? - Authors' reply

Stephen A Goutman1, Masha G Savelieff1, Eva L Feldman1

  • 1Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA.

The Lancet. Neurology
|August 13, 2022
PubMed
Summary

No abstract available in PubMed .

More Related Videos

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

9.7K
Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
08:59

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

2.7K

Related Experiment Videos

Last Updated: Sep 1, 2025

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons
07:43

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons

Published on: January 7, 2019

7.0K
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

9.7K
Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
08:59

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

2.7K

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

1.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.8K
Cross-bridge Cycle01:26

Cross-bridge Cycle

118.1K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
118.1K

Articles linked to this work by shared authors, journal, and citation graph.

Impact of modifiable risk factors, including diabetes, and diabetes-related complications, on dementia risk in older U.S. adults: mutually adjusted estimates from a population-based cohort.

Diabetes research and clinical practice·2026

Participant Experiences with EMPOWER: Benefits, Barriers, and Best Practices for an Online Peer Mentorship and Leadership Program for Women in Academic Medicine.

Women's health reports (New Rochelle, N.Y.)·2026

Diabetes and the Metabolic Syndrome as Drivers of Neurodegeneration: Convergent Mechanisms Linking Peripheral Neuropathy and Dementia.

Annals of neurology·2026

Peripheral Neutrophil Activation and Extracellular Trap Formation in Amyotrophic Lateral Sclerosis.

Annals of clinical and translational neurology·2026

Metabolic and Microvascular Risk Factors Associated With Brain Health in Type 1 Diabetes.

Annals of clinical and translational neurology·2026

Diabetic Peripheral Neuropathy May Be an Independent Risk Marker for Dementia and Cerebrovascular Disease.

Diabetes, obesity & metabolism·2026

Cholinesterase inhibitors in people with dementia with Lewy bodies and cardiac conduction abnormalities.

The Lancet. Neurology·2026

Advances in chronic subdural haematoma management: beyond the burr hole.

The Lancet. Neurology·2026

Antiseizure medication use in pregnancy and the risk of poor fetal growth in the EURAP international registry: a prospective cohort study.

The Lancet. Neurology·2026

Intensive blood pressure lowering after spontaneous intracerebral haemorrhage for secondary stroke prevention (RECAP-ICH): a systematic review and individual participant data meta-analysis.

The Lancet. Neurology·2026

Safety and efficacy of guanabenz in early-childhood onset vanishing white matter: primary analysis of a single-arm, phase 1/2 trial.

The Lancet. Neurology·2026

Tolerability, safety, and efficacy of atogepant versus topiramate in adults with migraine (TEMPLE): a randomised, head-to-head, phase 3b trial.

The Lancet. Neurology·2026

Comparative Experimental Raman, DFT, and Chemometric Characterization of Selected Phenolic Acids: Structural and Environmental Contributions to the Vibrational Response.

Molecules (Basel, Switzerland)·2026

Whole-Cell Fungal Biotransformation of para-Hydroxycinnamic Acids Mediated by Phenolic Acid Decarboxylase, Carboxylic Acid Reductase and Alcohol Dehydrogenase.

Molecules (Basel, Switzerland)·2026

Synthesis, Photophysical Investigation, and Nitroaromatic Sensing Properties of Novel Fused Pyrrolo[1,2-f]azolo[1,5-a]pteridines.

Journal of fluorescence·2026

Retraction notice to "Preparation and characterization of nano composites from metal oxides and activated carbon from banana peel (MO@BPAC, MO=NiO, CuO and ZnO) for 2 nitrophenol removal from aqueous solutions" [Heliyon 11 (2025) e41245].

Heliyon·2026

Protective role of Ocimum sanctum leaf extracts against rotenone induced cytotoxicity and oxidative stress in SH-SY5Y neuroblastoma cell line.

Toxicology in vitro : an international journal published in association with BIBRA·2026

Antioxidant Cymbopogon efficiency ratio (ACE) = (citronellal + citronellol)/(citral + geraniol) to determine the antioxidant capacity of the genus Cymbopogon.

Journal of the science of food and agriculture·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us